---
schema_version: "secwatch.filing_event.v1"
accession: "0001479681-25-000068"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2025-08-21T23:59:59+00:00"
generated_at: "2026-05-17T10:48:51.297453+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nutex Health restates FY2024 and Q1 2025; receives Nasdaq delisting notice for late filing

## Summary
- Restatement due to misclassification of obligations for under-construction hospitals; liabilities increase $10-20M (Dec 2024) and $20-50M (Mar 2025); equity decreases correspondingly.
- Material weakness in internal controls identified; company engaging accounting firm for remediation.
- Nasdaq notice for late filing of Q2 2025 10-Q; 60 days to file or submit compliance plan.
- Short seller report on July 22, 2025 caused stock drop of 16.5%; company disputes allegations.

## SEC filing metadata
- accession: 0001479681-25-000068
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2025-08-21T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 3.01, 4.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000068/0001479681-25-000068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000068/nutx-20250820.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001479681-25-000068
- JSON: https://secwatch.observer/filing/0001479681-25-000068.json
- Plain text: https://secwatch.observer/filing/0001479681-25-000068.txt

## Key facts
- Auditor Changes
  Nutex Health Inc. reported that prior financial statements should not be relied upon.
  - Action: non reliance
  source text: ber 31, 2024 (the “Original Form 10-K”) (collectively, the “Previously Issued Financial Statements”) treated non-cash obligations related to under-construction and ramping hospitals as equity rather than liabilities and should be restated. The Company does not anticipate any material changes for the first three quarters of interim financial statements for fiscal year 2024. The Company expects that any adjustments related to the treatment of these obligations will be non-cash in nature and have no effect on key financial statement line items such as its revenue, gross profit, liquidity, working capital, short-term and long-term debt, operating cash flow, adjusted EBITDA or number of patient visits as of and for the periods presented therein to be reflected in the fourth quarter of 2024. Accordingly, investors and all other persons should no longer rely upon the Previously Issued Financial
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000068/0001479681-25-000068-index.htm
- Listing & Compliance Notices
  Nutex Health Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: late filing
  - Rules: 5250(c)(1)
  source text: August 20, 2025, the Company received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the Company’s failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the “June 30, 2025 Form 10-Q”), with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC. Under Nasdaq r
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000068/0001479681-25-000068-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.